<DOC>
	<DOCNO>NCT02231944</DOCNO>
	<brief_summary>To compare first second recovery assessment Replenine®-VF evaluate recovery different batch patient change batch study . To evaluate Replenine®-VF term long-term clinical efficacy , tolerance safety</brief_summary>
	<brief_title>An Open Study Investigate Safety Efficacy Replenine®-VF Severe Haemophilia B Patients</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<criteria>Previously treat patient At least 12 year age Severe Haemophilia B without inhibitor factor IX</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>